Acknowledgments
We would like to thank the patients who participated in this study.
Medical writing support was provided by Mahalia Gilmartin, PhD and India
Wright, MSc, and editorial support was provided by Rachael Cazaly, BSc,
all of Core Medica, London, UK, supported by AstraZeneca according to
Good Publication Practice guidelines
(link).
The sponsor was involved in the study design and collection, analysis
and interpretation of data, as well as data checking of information
provided in the manuscript. However, ultimate responsibility for
opinions, conclusions and data interpretation lies with the authors.
Development of this manuscript was supported by AstraZeneca.
Disclosures
E. Palaka, N. Guzman, A. Dunn, E.T. Wittbrodt and S. Grandy are
employees and stockholders of AstraZeneca. F.O. Finkelstein has received
consultation fees from AstraZeneca, GSK,and Akebia.
Author
contributions
A. Dunn, S. Grandy, E. Palaka and E.T. Wittbrodt contributed to the
study design and data collection. E.T. Wittbrodt, E. Palaka, F.O.
Finkelstein, N. Guzman and S. Grandy performed the data analysis and
interpretation. All authors critically reviewed the manuscript, approved
the final version, and accept accountability for the overall work.
Data sharing
statement
Data underlying the findings described in this manuscript may be
obtained in accordance with AstraZeneca’s data sharing policy described
at:
https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.